| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xoma Royalty Corp (XOMA) has 12 insiders with recent SEC Form 4 filings, including 18 buys and 5 sells. XOMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $54.62M | - | |
| CEO | 102.0K | $4.21M | - | |
| CFO | 30.1K | $1.24M | - | |
| CFO | 30.0K | $1.24M | - | |
| Dir | 23.8K | $984.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 36,463 | $14.46 | $527,241.95 | +1.8% | |
| Dec 10, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 61,023 | $14.71 | $897,447.93 | +3.3% | |
| Dec 4, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 9,800 | $14.91 | $146,139.15 | +0.6% | |
| Nov 29, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 29,700 | $15.10 | $448,484.00 | +1.7% | |
| Nov 21, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 72,253 | $14.17 | $1,023,657.89 | +4.8% | |
| Nov 16, 2018 | Bvf Partners L P/il60 | 10% Owner | Buy | 31,990 | $13.48 | $431,347.68 | +3.5% | |
| Nov 15, 2018 | Van Ness W Denman | Director | Sale+OE | 5,528 | $12.67 | $70,039.76 | -37.7% | |
| Nov 13, 2018 | Neal James R76 | CEO | Buy | 4,000 | $13.26 | $53,056.40 | +24.5% | |
| Apr 27, 2018 | Neal James R76 | CEO | Sale+OE | 24,000 | $24.51 | $588,285.34 | -42.4% | |
| Apr 27, 2018 | Burns Thomas M.76 | SVP, Finance &CFO | Sale+OE | 11,000 | $24.71 | $271,806.91 | -45.6% |